Skip to main content

Market Overview

Affymetrix, Luminex Announce Distribution Agreement for Multiplexed Assay Instrument Platform


Inc. (NASDAQ: AFFX) and Luminex
Corporation (NASDAQ: LMNX) today announced a distribution agreement
under which eBioscience,
a business unit of Affymetrix, will sell Luminex's MAGPIX®,
Luminex® 200™ and FLEXMAP 3D® multiplexed assay
platforms in specified countries in the Americas, Asia and Europe.
Affymetrix will sell the Luminex instruments together with ProcartaPlex®
multiplexed immunoassays and QuantiGene® Plex multiplexed
quantitative gene expression assays, offering complete solutions to
customers working in the fields of drug discovery and development,
immuno-oncology and translational research. The agreement will
strengthen continued growth and adoption of Affymetrix' bead-based assay
portfolio, which serves markets growing at double-digit rates worldwide,

See full press release


Related Articles (AFFX)

View Comments and Join the Discussion!

Posted-In: News Contracts Press Releases

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at